A spinal fusion device is a type of medical implant used to treat spinal conditions like spinal stenosis, degenerative disc degeneration, and fractures. This surgical treatment involves the fusion of vertebrae in the spine using bone grafts and either plastic or metal cages, rods, screws, or plates. Stabilizing the spine, reducing discomfort, and enhancing the patient's overall spinal alignment and function are the main goals of spinal fusion surgery.

In 2021, the market for spinal fusion devices was USD 6.86 billion, and by 2030 it will reach USD 9.63 billion, growing at a 3.83% CAGR during the forecast period.

Due to the rising rate of spinal illnesses and ailments, such as degenerative disc disease and spinal instability, which necessitate spinal fusion surgery as a therapeutic option, there is an increased demand for spinal fusion devices. Asia-Pacific is driving a significant portion of the market growth for spinal fusion devices due to the region's aging population and increased spinal condition incidence.

Market Dynamics

Drivers

Due to different lifestyle factors like nutrition and smoking, the number of people with spinal diseases is rising. The NCBI estimates that spinal diseases affect 28.1% of people worldwide. The market trend for spinal fusion devices has improved due to the increasing number of seniors and individuals with spinal problems.

The rising use of surgical robots for spinal fusion aids in the upward trending growth of the world market for spinal fusion equipment. Because they are more successful at minimally invasive surgery, surgical robots are in higher demand. A study found that 80% of patients were happy with the outcome of a minimally invasive transforaminal lumbar interbody fusion, with a success rate between 60% and 70%.

Restraints

Over the forecast period, the market for spinal fusion devices will be hampered due to the strict regulations surrounding spinal devices.

Opportunity 

Throughout the forecast period, prominent market participants will launch more products. For instance, Spine Wave reported in December 2021 that the Defender Anterior Cervical Plate and the Stronghold C 3D Titanium Interbody Device, including TiCell 3D advanced surface technology, had been released immediately. During anterior cervical fusion procedures, fixation is provided by the Defender Anterior Cervical Plate, a titanium plate and screw system.

Market Segmentation 

By surgery 

In 2021, the open spine surgery had the largest market share. The need for open spine surgeries among medical experts, the rise in spinal anomalies, and advancements in spinal fusion technology all support the expansion of this market. For people who are experiencing hearing loss during this time, tele audiology can be a helpful approach to receiving care that removes or restricts traditional face-to-face involvement.

By Type

Due to the quick uptake of spine navigation software and appealing health insurance coverage, the cervical fixation devices segment ruled the market in 2021. By maintaining the construct's stability, cervical plates aid in fusion. The cutting-edge cervical interbody device is cylindrical and made of titanium alloy. While being implanted between two vertebrae, the device gathers the bone material required for fusion.

By End-User

In terms of revenue, the Hospitals market category held the largest market share for spinal fusion devices in 2021. Hospitals are observing considerable cost savings from spinal fusion procedures as a result of the growing use of modern spine surgery products and the progressive development in the number of robotic spine surgeries, which is projected to propel the market even further.

Regional Analysis

In 2020, North America held the greatest revenue share of over 41.0% in the market for spinal fusion devices. A number of important variables, including an aging population, an increase in spinal disorders, and an increase in sports injuries and fatal accidents, are driving the need for spinal fusion devices in North America. Also, the region's developed healthcare infrastructure will fuel market expansion. Moreover, advancements by major companies are anticipated to spur market expansion by creating enormous unrealized potential.

Asia Pacific will witness rapid spinal fusion device market growth due to a surge in medical tourism and government initiatives. Also, the region's expanding target population increases the danger of joint and spinal conditions.

Key Players 

• DePuy Synthes (a subsidiary of Johnson & Johnson, Inc.)
• Braun Melsungen AG
• SeaSpine
• Globus Medical
• Medtronic
• Orthofix Medical, Inc.
• Zimmer Biomet
• NuVasive, Inc.
• Spine Wave, Inc.
• Xtant Medical Holdings, Inc.
• Spineology

• ATEC Spine, Inc.
• Stryker
• Captiva Spine, Inc.
• Spinal Elements, Inc.

In 2021, the market for spinal fusion devices was USD 6.86 billion, and by 2030 it will reach USD 9.63 billion, growing at a 3.83% CAGR during the forecast period. The market is increasing due to an increase in spinal illnesses and the aging population.

Related Reports:

Oncology Drugs Market Report - The global oncology drugs market will witness a robust CAGR of 11.53%, valued at $177.54 billion in 2021, expected to appreciate and reach $474.06 billion by 2030, confirms Strategic Market Research.